Operational Excellence at a Full Valuation: Capital Markets Reaccelerate, AWM Records Continue, and the Sapphire Refresh Lands — but a "Cockroach" in Wholesale Credit and CET1 Under RWA Pressure Keep Us Disciplined
Key Takeaways
- Q3 2025 was a top-to-bottom operational beat: net income of $14.4B, EPS of $5.07, and a 20% ROTCE on revenue of $47.1B (+9% YoY). Every operating segment grew revenue: CCB $19.5B (+9%), CIB $19.9B (+17%), AWM record $6.1B (+12%). Markets revenue carried the headline (FICC +21%, Equities +33%), IB fees rose +16% on equity-underwriting strength, and AWM took in $72B of long-term net inflows with AUM at $4.6T (+18%).
- Credit cost of $3.4B — net charge-offs $2.6B and a $810M reserve build — was elevated by two idiosyncratic wholesale events ($170M Tricolor charge-off plus a couple of "apparent fraud" instances in secured lending). On the consumer side, early-stage delinquencies are "stable and slightly better than expected" and the firm took the 2025 card NCO outlook DOWN to ~3.3% on favorable delinquency trends. The wholesale signal is the more interesting one and the one that matters for the next twelve months.
- Dimon's "cockroach" framing is the quote of the quarter and the central reason we are not getting more constructive: when asked about Tricolor + First Brands, he said "when you see one cockroach, there are probably more... everyone should be forewarned on this one." Coming from a CEO who is professionally calibrated to under-promise on credit, that is not a throwaway line. We read it as Dimon explicitly flagging a wholesale credit normalization (and possibly more than normalization) playing out beneath a benign aggregate read.
- Capital trajectory tightening: CET1 at 14.8%, down 30 bps QoQ, driven by RWA growth from "increased wholesale lending across both banking and markets." Management explicitly said they "do not love buying back the stock at these levels" and reiterated that organic deployment (the announced ~$1.5T critical-industries lending push, $10B of direct equity investments) is the preferred capital use over buybacks. Buyback cadence is structurally lower until the stock corrects or RWA growth slows.
- Forward framing was unusually concrete for a Q3 call: Q4 NII ex-markets ~$23.5B, total Q4 NII ~$25B, FY25 adjusted expense ~$95.9B, and a preliminary 2026 NII ex-markets central case of ~$95B — with Barnum noting that consensus 2026 expense of ~$100B "does look a little bit low." That last comment is the read that sell-side desks will spend the next two weeks digesting; expense growth in the ~4% range into 2026 is the new normal, not a glitch.
- Rating: Maintaining Hold (constructive bias). The Q3 print confirms the operating thesis we initiated in Q2: best-in-class franchise, 20% ROTCE in any environment, multi-segment compounding. But the stock is at or near all-time highs into a setup where (a) the wholesale credit cycle is starting to normalize with idiosyncratic surprises, (b) CET1 buffer is shrinking against RWA growth, (c) buyback support is structurally lower, and (d) the 2026 NII central case is below where bullish models had landed. We continue to prefer waiting for either a meaningful drawdown or a credit-cycle clarification before adding to the rating; maintaining Hold with constructive operating bias.
Rating Action: Maintaining Hold (Q2 Initiation Confirmed)
We initiated coverage at Hold (with a constructive bias) at our Q2 2025 update. The rating logic at the time was: best-in-class operating franchise compounding through any rate environment, 20%-plus ROTCE durably, but a valuation that was already pricing in dominance and a forward setup where (i) NII tailwinds were rolling over as the Fed cut, (ii) capital return optionality was constrained by a stock at premium-to-book multiples, and (iii) the credit cycle was poised to start normalizing from generationally low levels. We argued the right way to own JPM at that valuation was to wait for an entry where any of those three risks visibly materialized.
Q3 2025 confirms the operating side of the thesis without changing the entry-point arithmetic. The print was excellent across every line we monitor — markets reacceleration, IB pickup, AWM records, consumer credit better-than-expected, expense discipline holding — and the Q4 / preliminary 2026 framing was direct and credible rather than evasive. None of that is contested. What is also true: the stock has continued to grind higher into the print, the Tricolor episode is the first concrete evidence that the wholesale credit cycle is starting to bite, Dimon's "cockroach" framing is the most pointed credit-cycle warning he has issued in this coverage period, CET1 has moved from ~15.4% earlier in the year toward 14.8% with explicit management guidance that buyback support is muted at current prices, and Barnum's "$100B is a little bit low" expense framing for 2026 means the operating-leverage tailwind will be more muted than bullish models had carried. The arithmetic that argued for Hold in Q2 is, if anything, slightly more pointed today.
Two things would move us to Outperform: (1) a 10-15% drawdown without thesis impairment — the price-action setup is positioning-sensitive into year-end and an AI-complex / regional-bank / NBFI-credit shock is the obvious catalyst — or (2) clear evidence that the wholesale credit normalization is contained at a few idiosyncratic names rather than a directional shift. Neither is in hand today. Maintaining Hold.
Results vs. Consensus
Q3 was a clean operating beat across the major lines. Reported revenue, NII, fee revenue, EPS, and ROTCE were all at or above the bullish-end-of-range Street modeling, with no significant misses on any major operating metric. The areas of incremental concern are not in the Q3 actuals but in the forward framing: capital trajectory, 2026 expense outlook, and the wholesale credit signaling.
| Metric | Actual Q3 2025 | Consensus (approx.) | Beat/Miss | Notes |
|---|---|---|---|---|
| Revenue (managed) | $47.1B | ~$45.5B | Beat | +9% YoY; markets-led |
| EPS | $5.07 | ~$4.85 | Beat | ~+4% above Street |
| Net income | $14.4B | ~$13.6B | Beat | +12% YoY (firmwide) |
| ROTCE | 20% | ~18% | Beat | Through-cycle target ~17% |
| NII (firmwide) | ~$24.5B | ~$23.6B | Beat | Balance-sheet growth offsetting rate drag |
| Expense | $24.3B | ~$23.9B | In-line/miss | +8% YoY; revenue-related comp + investment |
| Credit cost | $3.4B | ~$3.0B | Miss | NCO $2.6B + reserve build $810M; Tricolor flagged |
| CET1 ratio | 14.8% | ~15.0% | Miss | -30 bps QoQ on RWA growth |
| IB fees | +16% YoY | ~+10% | Beat | Equity underwriting led |
| FICC / Equities | +21% / +33% | ~+12% / +18% | Beat | Equities particularly strong on Prime |
| AUM | $4.6T | n/a | Record | +18% YoY; $72B Q3 net inflows |
Quality of Beat
- Revenue mix: The $47.1B / +9% YoY headline is led by markets revenue (FICC +21%, Equities +33%) and supported by fees across asset management, IB, and payments. NII rose on balance-sheet growth and mix offsetting lower rates. The composition is favorable: capital-markets fees and AWM fees are the higher-quality revenue lines and they drove the upside, rather than NII surprise-positive trading. This is the kind of revenue beat that supports forward operating leverage.
- Expense discipline holding within the noise: $24.3B (+8% YoY) is at the high end of the bands but is being driven by revenue-related expense (variable comp tied to the markets / IB upside) and continued AI/tech investment. Barnum was explicit that fixed expense growth is being constrained by headcount discipline, and that productivity from AI investment is being captured in slower aggregate growth rather than line-item savings. This is a sustainable framing.
- Credit quality on the consumer side — better than expected: Consumer and small business "remain resilient" per management, early-stage delinquencies are "stable and slightly better than expected," and the firm took the 2025 card NCO outlook DOWN to ~3.3% from prior framing. That is an unambiguously positive read on the consumer cycle and one that we would not have predicted at our Q2 update.
- Credit quality on the wholesale side — the area of concern: $170M of charge-offs from Tricolor (a subprime auto lender that filed Chapter 11 in late September) plus "a couple of instances of apparent fraud in certain secured lending facilities" drove wholesale charge-offs above the recent run rate. The dollar magnitude is small relative to the franchise; the signaling is the bigger issue. See the next section.
- Capital return mechanics: CET1 of 14.8% (-30 bps QoQ) reflects RWA growth in wholesale lending and markets activity. Management was explicit that they "do not love buying back the stock at these levels" and would prefer to deploy capital into the real economy, including the announced ~$1.5T critical-industries lending push and $10B of direct equity investments over a multi-year horizon. This is operationally rational but is also the framing that caps near-term EPS accretion from buyback shrink.
Segment Performance
| Segment | Revenue | YoY | Net Income | Notable |
|---|---|---|---|---|
| CCB (Consumer & Community Banking) | $19.5B | +9% | $5.0B | Sapphire refresh = best year ever for new accounts; #1 retail deposit share, 5th year |
| CIB (Commercial & Investment Bank) | $19.9B | +17% | $6.9B | IB fees +16%, FICC +21%, Equities +33%, payments solid; pipeline "robust" |
| AWM (Asset & Wealth Management) | $6.1B (record) | +12% | $1.7B | AUM $4.6T +18%, client assets $6.8T +20%, $72B Q3 net inflows; pretax margin 36% |
| Corporate | $1.7B | n/m | $0.82B | Treasury / corporate items |
CCB: Sapphire Lands, Consumer Resilient
CCB net income of $5.0B on $19.5B revenue (+9% YoY) was driven predominantly by higher NII on higher revolving balances. Three operationally meaningful data points beneath the headline: (1) over 400,000 net new checking accounts in the quarter, sustaining the run-rate that underpins the long-term 15% retail deposit share aspiration; (2) retained #1 retail deposit share in a flat deposit market for the fifth consecutive year per FDIC data; and (3) the Sapphire refresh has driven "the best year ever for new account acquisitions" in the Sapphire portfolio.
"Consumers and small businesses remain resilient based on our data. While we are closely watching the potentially softening labor market, our credit metrics including early-stage delinquencies remain stable and slightly better than expected." — Jeremy Barnum, CFO
The card NCO trajectory is the cleanest evidence of consumer resilience. Management took the 2025 card NCO outlook DOWN to ~3.3% on favorable delinquency trends — this is the inverse of the "normalization is becoming deterioration" risk the bear case has been carrying. Meanwhile, the Sapphire refresh accounting dynamic is worth flagging for modeling purposes: customers are receiving increased value AHEAD of the moment annual fees go up, which is producing slightly elevated rewards-amortization charges (visible as a negative card NIR yield) for a few quarters before normalizing.
"There is a kind of transitional period of a few months as the refresh rolls through. Those numbers are slightly elevated. The fee comes in over a year and some of these rewards come in as negative NII over a year." — Jeremy Barnum, on Sapphire refresh accounting
One operational tension worth flagging: at Investor Day, CCB framed deposit growth of 3% by Q4 2025 and 6% in 2026 as the "central case." Q3 deposits were "flat" rather than growing, with Barnum attributing the gap to (a) personal savings rate slightly lower than expected, (b) strong equity-market performance pulling household flows into investments and AWM, and (c) yield-seeking flows on rates a bit higher than the prior forward curve. Barnum explicitly said the upward inflection has been "pushed out a little bit" but reiterated long-term confidence in the trajectory.
Assessment: CCB is executing well at the franchise level — account growth, share retention, Sapphire receptivity all support the long-term compounding case. The deposit-growth slip is macro-driven and the kind of thing that reverses on a labor-market softening (which would shift balances back into bank deposits). Net: CCB is a positive in the print but does not move the rating.
CIB: The Reacceleration in Capital Markets the Thesis Wanted
CIB net income of $6.9B on $19.9B revenue (+17% YoY) is the standout segment of the quarter. The composition: IB fees +16% YoY with "particular strength in equity underwriting as the IPO market was active"; FICC +21% on rates and credit plus securitized products; Equities +33% with notable Prime outperformance; and payments revenues continuing to compound.
"Our pipeline remains robust and the outlook along with the market backdrop and client sentiment continues to be upbeat." — Jeremy Barnum, on IB pipeline
Barnum's later commentary on M&A activity reinforces the framing: he noted this was "the busiest summer we have had in like a long time in terms of announced M&A activity," with that flow rolling into acquisition finance, and IPO processes that had been kicked off earlier in the year now pushing through into actual launches as conditions improved. The "animal spirits" framing he used — revived deal flow, sponsor activity coming back, full product-suite leverage — is a meaningful tonal shift from the cautious framing of late 2024 and is consistent with what we have heard from Goldman and Morgan Stanley desk-level commentary.
One data point worth specifically isolating: Equities +33% YoY with Prime outperformance. Prime brokerage revenue is a leading indicator for hedge-fund leverage demand, and a +33% print on a comp that included the Q3 2024 spike on the Aug 5 vol event is operationally meaningful. The institutional-trading franchise is benefiting from both higher deployed leverage AND broader client engagement — a quality combination.
Assessment: CIB is the segment where the operating story most clearly improved this quarter. The IB pipeline / animal-spirits framing is the kind of forward indicator that supports a 1H 2026 capital markets fee acceleration thesis. Our concern: the environment "can change overnight" (Barnum's words) and the pipeline-to-realization translation is sentiment-dependent. We continue to model CIB conservatively and treat the Q3 strength as confirmation of franchise quality rather than as evidence of a structural step-up.
AWM: Records on Records
AWM produced its third consecutive record-revenue quarter at $6.1B (+12% YoY) with a 36% pretax margin. AUM reached $4.6T (+18% YoY) and client assets reached $6.8T (+20% YoY), with $72B of long-term net inflows in Q3 led by fixed income and equities. Net income of $1.7B reflects the operating leverage characteristic of the asset-management franchise — revenue growth of 12% translating to outsized profit growth as cost base scales sublinearly.
The longer-term significance of AWM is its strategic role as the wealth-aggregation arm capturing flows out of CCB deposits as households move balances into higher-yielding investment products. Barnum explicitly framed equity-market strength driving "flows into investments, and we are capturing that in our Wealth Management business" — the deposit-growth shortfall in CCB is being partially recaptured at the consolidated firm level via AWM. This is the strategic value of the integrated bank-plus-wealth model that JPM has built and that pure-play retail banks lack.
Assessment: AWM at $4.6T AUM with 18% growth and 36% margin is one of the most operationally attractive franchises in the firm. We treat it as the highest-quality compounder in the JPM portfolio and one of the structural reasons to retain a constructive bias even at full valuation.
Wholesale Credit: The "Cockroach" Quote and Why It Matters
"I probably should not say this, but when you see one cockroach, there are probably more. And so we should — everyone should be forewarned on this one. And first brands, I would put in the same category, couple of other ones out there I have seen I put in similar categories... It clearly was, in my opinion, fraud involved in a bunch of these things." — Jamie Dimon, Chairman & CEO
Three things to unpack:
- What Tricolor actually was. Tricolor Holdings is a subprime auto lender that filed Chapter 11 in September 2025; JPM's $170M of charge-offs in Q3 represents balance-sheet exposure being written off, with management declining to comment on additional exposures pending. JPM has confirmed it has no exposure to First Brands. The dollar magnitude of Tricolor (~$170M) is trivial against JPM's earnings power; the question is the second-order signal.
- Dimon's framing is unusually direct. Dimon has spent the last several quarters carrying a generic "we have had a benign credit environment for a long time" caution. The "cockroach" line is materially more pointed: it is a CEO who is professionally calibrated to under-promise on credit explicitly stating his expectation that further idiosyncratic surprises are coming. The relevant translation: bear stories on subprime auto, certain BDCs, and pockets of private credit are about to get harder to dismiss.
- The "downturn would be worse than people expect" line is doing real work. Dimon went further: he expects that in a downturn, "credit in other places deteriorate a little bit more than people think... we have had a bull market for a long time. Asset prices are high. A lot of credit stuff that you would see out there, will only see that it is a downturn." This is not a base-case forecast — Barnum was explicit that "tipping point is a little bit too strong a word" — but it is the most pointed downturn-risk framing Dimon has put on a call in this coverage cycle.
To be clear: the wholesale book in aggregate is performing in line with expectations, the consumer is healthy, and Tricolor is a single-name idiosyncratic. We are NOT calling a credit cycle. What we are saying is that the signal-to-noise on Dimon's framing has shifted, and the right posture for a long position in JPM into year-end is to be calibrated to the possibility that wholesale charge-offs run modestly higher than benign-cycle norms in 2026 — especially in NBFI / private-credit-adjacent exposures — and that the reserve build trajectory may reaccelerate.
NDFI / Private Credit Exposure Framework
Erika Najarian (UBS) pressed for the right questions to ask about NDFI exposure, and Dimon & Barnum gave a more substantive framework than usual:
- The vast majority of JPM's NDFI lending is highly secured, structured, or securitized — not high-risk, low-rated direct lending. The Tricolor exposure is "secured lending," and the loss is fundamentally a collateral-quality issue (alleged fraud) rather than an unsecured-credit deterioration.
- "Probably half" of NDFI is "very traditional" in Dimon's framing — the kind of secured lending to large asset managers and infrastructure capital that has functioned the same way for decades. The other half is "different today than it was years ago" — including direct lending to leveraged entities and CLO structures with "double leverage" embedded.
- The "different" portion is where Dimon expects downturn surprises: "I would suspect that some of those deals may not be as good as you think... I think you would be a little bit worse" than in prior cycles.
Assessment: JPM's individual NDFI exposure profile remains conservative within the industry — secured-lending tilt, granular wholesale reserve methodology, day-one reserves on direct-lending originations. Dimon's framing is not an indictment of JPM specifically but a system-level caution. We treat the exposure as well-managed within the franchise but as an area where headline-risk events (more Tricolor-like single-names) are likely over the next 12 months.
Capital, Buybacks, and the Critical-Industries Pivot
CET1 of 14.8% is down 30 bps from Q2's ~15.1%, with management attributing the decline to RWA growth from "increased wholesale lending across both banking and markets as well as other markets activities." The buffer above the regulatory minimum remains substantial, but the trajectory matters: from ~15.4% earlier in 2025 toward 14.8% in Q3 is a clear tightening and one that constrains buyback flexibility absent a reversal.
The capital-return commentary was unusually direct:
"We do not love buying back the stock at these levels, but we want to keep the reasonable. And in the meantime, we are using our financial resources to lend into the real economy very broadly across the entire franchise." — Jeremy Barnum, CFO
Three implications:
- Buyback as a residual, not a primary capital lever. The framing is consistent with what JPM has been signaling for several quarters: stock at premium-to-book multiples + organic-deployment opportunities > mechanical buyback. Investors modeling EPS accretion from buyback shrink should be conservative.
- The "high trillion dollars" critical-industries lending pivot is real RWA consumption. The October press release cited by Betsy Graseck (Morgan Stanley) frames an aspiration to deploy ~$1.5T of additional lending toward U.S. national-security-related industries over a multi-year horizon, plus $10B of direct equity investments. Whether or not the dollar magnitude is fully achieved, the directional commitment is incremental RWA consumption that competes with buyback for excess capital.
- Dividend trajectory unchanged. Barnum did not give forward dividend guidance but the "all of the above" framing suggests dividend hikes remain in the toolkit alongside buybacks.
Assessment: The capital framework is operationally rational and consistent with management's long-stated philosophy. From an investment-case perspective, it caps the "buyback shrink-driven EPS upside" lever that has historically been a multi-turn re-rate driver for large-cap banks. JPM's case for owning has to lean more on operating earnings growth and less on share-count reduction in 2026 than in 2024.
Q4 2025 Guidance and Preliminary 2026 Framework
| Metric | Q4 2025 Guide | FY2025 Implied | FY2026 Preliminary |
|---|---|---|---|
| NII ex-Markets | ~$23.5B | ~$92.5B (full-year math) | ~$95B central case |
| Total NII | ~$25B | n/a | Not yet provided |
| Adjusted Expense | ~$24.5B | ~$95.9B | "$100B looks a little bit low" |
| Card NCO Rate | n/a (run-rate) | ~3.3% (down from prior) | To be provided at Q4 print |
Two pieces of forward framing matter most:
2026 NII ex-Markets: ~$95B Central Case
The number is constructive in absolute terms but is below where the most bullish sell-side models had landed (some desks had carried $97-100B for 2026). The framing assumes the September-30 forward curve, which embedded 75 bps of cuts in 2025 and two 25 bp cuts in 2026, plus continued asset-sensitivity drag. The offset: card revolve growth (slowing as normalization completes), deposit balance growth (a growth driver but more muted than the Investor Day central case implied), wholesale loan growth (solid trends). The composition: rate headwind offsetting balance-and-mix growth.
Read: The 2026 NII central case is realistic rather than bullish. Investors who had carried $97B+ will need to mark down. The $95B framing also has the usual "preliminary, subject to budget cycle" caveats — the actual Q4 print will refine.
2026 Expense: ~$100B Consensus "Looks a Little Bit Low"
This is the line that will get the most attention from sell-side desks over the coming weeks. Barnum's logic: take the Q4 ~$24.5B run-rate, annualize, adjust for seasonality, add expected labor inflation (3-4% framing), revenue-related variable comp, and growth investment — and the math lands above $100B. Erika Najarian (UBS) characterized it as "the new normal labor rate inflation" and Barnum confirmed something in that range is structural.
Dimon added a substantive piece on medical-cost inflation: "We spent $3 billion of so in medical. Going be up 10% next year. And so when you look at some of these things and we know that already and maybe think it actually might be up another 10% in 2027." Plus competitive comp pressure from non-bank pay-setters (hedge funds, law firms, PE, NBFIs).
Read: 2026 expense growth in the ~4% range is the new normal. The AI productivity story is real but is being captured in lower-than-otherwise expense growth rather than absolute savings. Investors should be modeling FY26 expense in the $100-104B range rather than the bullish $98-100B that some models had carried.
Analyst Q&A Highlights
NII Trajectory and Deposit Growth
- John McDonald, Truist Securities: Asked about retail deposit assumptions in the 2026 NII outlook given Q3 deposits were flat versus Investor Day's 3% / 6% growth framing. Barnum confirmed the upward inflection has been "pushed out a little bit" due to lower personal savings rate, equity-market-driven flows into AWM, and yield-seeking dynamics, but reiterated long-term confidence in the trajectory.
Assessment: Deposit-growth shortfall is macro-driven and reversible. The 2026 NII central case of ~$95B is realistic; bull-case models that carried 6% deposit growth as a baseline will need to mark down.
Wholesale Credit and NBFI Exposure
- Glenn Schorr, Evercore ISI: Asked about credit demand drivers and whether JPM was seeing differentiated fundamentals between public and private credit markets. Barnum framed wholesale demand as "revived animal spirits," with deal flow "very healthy" and acquisition finance "back," and characterized JPM's product-agnostic credit strategy as a competitive advantage in the current environment. On public/private differentiation he was cautious, noting that direct-lending wholesale charge-offs are likely structurally higher than the GFC-era ~zero rate.
Assessment: Demand framing is the most positive Barnum has given on capital markets in this coverage period. The public/private differentiation is intentionally hedged. - Mike Mayo, Wells Fargo: Probed the NDFI exposure framework and asked whether Dimon viewed it as "flashing yellow." This prompted the "cockroach" exchange.
Assessment: The Mayo question was the most operationally important of the call and Dimon's response was the most pointed credit-cycle warning he has issued in this coverage period. See "Wholesale Credit" section above. - Erika Najarian, UBS: Pressed for a structured framework on NDFI exposure questions and on SSFA risk-weighting accounting in securitization structures. Barnum and Dimon together produced the "vast majority is highly secured" framing and the "half is traditional, half has double leverage" categorization.
Assessment: This is the framework analysts and risk managers will use to triangulate NDFI exposure across the bank universe over the next two quarters. It is also a useful reminder that JPM-specific exposure is more conservative than industry NDFI averages.
Capital Deployment and Buyback Cadence
- Betsy Graseck, Morgan Stanley: Asked about excess capital utilization across the announced ~$1.5T critical-industries lending push, $10B of direct equity investments, and dividend hike potential. Barnum gave the "all of the above" framing and reiterated discipline on stock-level pricing for buybacks.
Assessment: Capital deployment philosophy is consistent with the long-stated framework. Buyback support is structurally lower at current valuations until the stock corrects or RWA growth slows. - Jim Mitchell, Seaport Global: Asked about marginal-return activities to lean into versus buybacks at full valuations. Barnum was explicit that the math comparing buyback ROIC to alternative business deployment is a daily exercise, with the discipline of avoiding "really dumb risk decisions" by chasing nominal return spreads.
Assessment: This is the framework that has been driving the multi-year shift toward organic deployment. Investors should expect the trend to continue.
Macro Outlook and AI Productivity
- Ebrahim Poonawala, Bank of America: Asked whether 2026 was a tipping point for the labor market and credit cycle. Barnum: "tipping point is a little bit too strong a word" but acknowledged it is "pretty easy to imagine a world where the labor market deteriorates from here." Also pressed on AI productivity gains: Barnum framed JPM's posture as "old-fashioned expense discipline" rather than measured AI savings, with the bias toward constraining headcount growth and trusting that productivity tailwinds will show up in lower-than-otherwise expense growth.
Assessment: The AI framing is the most analytically honest answer we have heard from a large-bank CFO. The "we are not going to scramble around to use AI in ways that are not efficient" line is the right operating posture.
Investment Banking Pipeline
- Jim Mitchell, Seaport Global: Asked where the most strength is in the IB pipeline and whether sponsor activity is picking up. Barnum cited equity underwriting as particularly strong, noted M&A activity at the busiest summer pace "in a long time," and was somewhat skeptical that further rate cuts (already priced in) would drive incremental sponsor activity.
Assessment: The IB pipeline framing is the most constructive of any large-bank Q3 commentary so far. Whether it translates into actual revenue depends on the sentiment environment holding, which Barnum himself flagged "can change overnight."
Regulation and Basel III Endgame
- Gerard Cassidy, RBC Capital Markets: Asked about the regulatory environment under the new administration and timing on Basel III Endgame. Barnum framed the regulatory direction as "bias for action, getting things done quickly," with comprehensive review of capital rules at the individual product level rather than aggregate calibration. Dimon added direct critique of GSIB, CCAR, operational risk capital, and trading-book double-counting.
Assessment: The regulatory backdrop is the most favorable in the post-GFC era for systemically important banks like JPM. A meaningful capital-rule recalibration in 2026 would be incremental upside to our current framework, but is not yet in our base case.
What They're NOT Saying
- Tricolor exposure beyond the $170M charge-off. Barnum explicitly declined to comment on additional Tricolor-related exposures, saying "It will play out as it plays out." This is highly unusual specificity-avoidance from JPM and suggests further P&L impact is possible — though management's stated practice of "taking all possible hits that we can based on what is knowable upfront" implies the bulk should already be reserved.
- The other "cockroaches" Dimon referenced. Dimon said "couple of other ones out there I have seen I put in similar categories" but did not name them. This is the single most important undisclosed information from the call — sell-side desks will spend October and November trying to triangulate which other private-credit / NBFI names are at elevated risk.
- 2026 expense framework. Beyond the "$100B is a little bit low" hint, no specific 2026 expense guide. The full framework arrives at Q4 print or at the February company-update event.
- 2026 card NCO rate. Will be provided at Q4 earnings. Given the favorable 2025 trajectory, the 2026 rate could come in below the recent ~3.5% baseline.
- Buyback cadence specifics. No forward guidance on buyback dollars by quarter. Investors should assume modest buybacks at current prices, with the option to accelerate if the stock corrects or CET1 trajectory eases.
- The CET1 floor management is targeting. 14.8% is well above the regulatory minimum but the trajectory direction matters. Management did not communicate where CET1 would have to fall to before they would re-evaluate the deployment-vs-buyback mix.
- Sapphire economics post-refresh-period. The transitional accounting drag on card NIR yield is acknowledged but the full normalized economics — new fee level vs. new rewards-amortization run-rate — are not yet quantified.
Market Reaction
- Pre-print context: JPM entered the print near all-time highs after a multi-quarter rally, with the stock having outperformed the BKX index by a meaningful margin year-to-date. Forward P/E entering the print was elevated by historical large-cap-bank standards. Positioning was concentrated long among institutional investors.
- Initial reaction: Stock traded modestly down on the print despite the across-the-board operational beat. The cited reasons in initial sell-side coverage: (a) the Tricolor charge-off and Dimon's "cockroach" framing read as risk-off for the broader bank complex; (b) the 2026 NII central case of ~$95B was below the most bullish sell-side models; (c) the "$100B is a little bit low" 2026 expense framing implied less operating leverage than bull cases had carried; (d) CET1 at 14.8% with explicit muted-buyback guidance reduced near-term EPS-accretion optionality.
- Sell-side response framework: Most desks are likely to maintain current ratings and modestly trim 2026 EPS estimates on the NII / expense framing. The Tricolor / "cockroach" framing is more likely to drive negative read-through to subprime-auto-exposed lenders, BDCs, and specialty-finance names than to JPM specifically.
- Volume: Elevated vs 30-day average on the print session.
The sell-off is rational and is more about sector positioning than JPM-specific concerns. The Q3 print is operationally excellent; the issues are forward (NII, expense, capital deployment) and contextual (the broader large-bank complex is at elevated valuations into a regulatory and credit transition). For JPM specifically, the print does not change the operating thesis — but it also does not improve the entry-point arithmetic, which is the variable that drives the rating.
Street Perspective
Debate: Is the "cockroach" framing a meaningful credit-cycle warning or Dimon being Dimon?
Bull view: Dimon has spent the last four quarters issuing generic credit-cycle cautions; the "cockroach" line is rhetorically pointed but operationally a continuation of the same framing. The aggregate wholesale book is performing in line with expectations; consumer credit is better than expected; 2025 card NCO outlook went DOWN. The absence of a real cycle is the right read; "cockroach" is a deflection from a single-name fraud event, not a directional warning.
Bear view: The "cockroach" line is the first time Dimon has explicitly flagged that the wholesale credit cycle is starting to bite. Tricolor + the "couple of other ones" Dimon referenced + the "downturn would be worse than people think" framing collectively represent the sharpest credit-cycle warning of the post-GFC era from JPM. The right read is that wholesale charge-offs run modestly above benign-cycle norms in 2026 and that headline-risk events accelerate.
Our take: The bear is more right than wrong on the signaling, but the bull is right that it is not yet a directional cycle. The "cockroach" line is a calibrated warning — an explicit invitation to investors to discount aggregate credit metrics and pay attention to single-name surprises. We treat it as evidence to maintain caution on the entry point rather than as a sell signal.
Debate: Does the 2026 NII / expense framing change the EPS trajectory?
Bull view: 2026 NII ex-markets of ~$95B and expense modestly above $100B implies pre-tax pre-provision earnings power that compounds high-single-digits even in a benign environment. Layer in mid-cycle ROTCE of 18-20%, and FY26 EPS in the ~$22 range is the floor. With buyback support resuming as RWA growth normalizes and the regulatory rule recalibration providing potential capital relief, the EPS trajectory is materially better than the framing implies.
Bear view: 2026 EPS estimates that had carried $23-24 on bullish NII / expense assumptions need to come down to the $21-22 range. With buyback support muted at current prices and capital being deployed organically rather than returned, the share-count tailwind is muted relative to history. Combined with normalization of credit cost off generationally low levels, FY26 EPS could land below $21 in a more cautious scenario.
Our take: The bull is roughly right on the operating earnings power but the bear is right that the path to higher EPS estimates is constrained. We model FY26 EPS in the $21-22.50 range, with the upper end requiring (a) credit cost staying at current levels, (b) capital markets sustaining the +15% YoY pace, and (c) some buyback acceleration if the stock corrects.
Debate: Is the IB / capital markets reacceleration sustainable or a Q3 high-water mark?
Bull view: The pipeline framing is the strongest in years; M&A activity has pushed through the Liberation Day uncertainty, the IPO queue is loaded with deals waiting on the right window, and rate cuts (even if priced in) plus continued equity-market strength provide a supportive backdrop. CIB revenue compounds at a higher pace through 2026 than the +17% Q3 print, with FICC and Equities both sustaining double-digit growth.
Bear view: The Q3 print includes a major equity-underwriting bulge (the "particularly large deal" Barnum referenced is likely the StubHub IPO) that is not necessarily representative of run-rate. Markets revenue is positioning-sensitive and will moderate as volatility compresses. The IB pipeline is sentiment-dependent and "can change overnight" (Barnum's words) on any equity-market or geopolitical shock.
Our take: The bull case is consistent with what we are hearing from peer desks, but the bear's positioning-sensitivity point is real. We model CIB revenue growth in the +8-12% range for 2026 — positive but moderating from the +17% Q3 pace as comps get harder and volatility normalizes.
Model Implications
| Item | Pre-Print Model | Suggested Update | Reason |
|---|---|---|---|
| FY25 Revenue | ~$172-175B | ~$175-178B | Q3 beat plus Q4 NII / capital markets implied trajectory |
| FY25 EPS | ~$19.00-19.75 | ~$19.75-20.25 | Q3 EPS beat plus better consumer credit trajectory |
| FY25 ROTCE | ~19% | ~20% | Q3 ROTCE 20% with broad-based segment contribution |
| FY26 NII ex-Markets | ~$97B | ~$95B | Management central case; rate-headwind drag through 1H |
| FY26 Expense | ~$98-100B | ~$100-104B | "Looks a little bit low" framing; medical inflation; comp pressure |
| FY26 Card NCO Rate | ~3.5% | ~3.2-3.4% | 2025 favorable trajectory carries into 2026 |
| FY26 EPS | ~$22.00-23.50 | ~$21.00-22.50 | Lower NII central case + higher expense + muted buyback |
| FY26 CET1 (year-end) | ~15.0-15.5% | ~14.5-15.0% | Continued RWA growth from critical-industries lending pivot |
| FY26 ROTCE | ~18-19% | ~17-18% | Through-cycle target rather than the 20% Q3 print |
Valuation framework: At the Q3 print closing price (mid-$310s area), JPM trades at roughly 14-15x our updated FY26 EPS midpoint and ~2.4x tangible book. Both metrics are at or above historical-cycle highs for the franchise. Our framework fair value range moves modestly to $295-330 (from ~$285-320 at Q2 update), reflecting the operational confirmation but also the now-tighter capital deployment outlook and the 2026 EPS markdown. The post-print pricing is roughly at the upper end of fair value — consistent with the operating quality being recognized but limiting room for multi-quarter outperformance absent a meaningful drawdown or re-rating catalyst.
Thesis Scorecard Post-Earnings
| Thesis Point | Status | Notes |
|---|---|---|
| Bull #1: Best-in-class operating franchise compounds through any cycle | Strongly confirmed | Q3 beat across every segment; 20% ROTCE; AWM record on record |
| Bull #2: Sapphire / consumer engagement franchise drives durable retail value | Confirmed | Best year ever for Sapphire new accounts; 5th year #1 retail deposit share |
| Bull #3: CIB pipeline supports sustained capital markets reacceleration into 2026 | Confirmed | +17% revenue, +16% IB fees, "robust" pipeline framing; busiest M&A summer "in a long time" |
| Bull #4: AWM scale + operating leverage = highest-quality franchise compounder | Strongly confirmed | $4.6T AUM +18%, $72B Q3 inflows, 36% pretax margin; record revenue |
| Bull #5: Consumer credit normalizing rather than deteriorating | Confirmed | 2025 card NCO outlook revised DOWN to ~3.3%; early-stage delinquencies stable |
| Bull #6: Regulatory tailwind from comprehensive capital-rule recalibration | Building | "Bias for action" from regulators; Basel III Endgame timing still TBD |
| Bear #1: Valuation full at premium-to-book; limited multiple upside | Confirmed | Stock at ~2.4x tangible book; muted buyback at these levels by management's own framing |
| Bear #2: NII rolls over as Fed cuts; balance-sheet growth offset insufficient | In progress | 2026 NII ex-markets ~$95B is below bullish modeling; rate-asymmetry drag continues |
| Bear #3: Wholesale credit normalization with idiosyncratic surprises | Materializing | Tricolor $170M + Dimon's "cockroach" framing = first concrete evidence of cycle bite |
| Bear #4: CET1 trajectory tightening on RWA growth limits buyback flexibility | Confirmed | 14.8% from ~15.4% earlier in year; explicit muted-buyback guidance from CFO |
| Bear #5: 2026 expense growth structurally elevated by labor / medical / comp pressure | Confirmed | "$100B is a little bit low"; medical +10% YoY both 2026 and 2027; non-bank comp pressure |
| Bear #6 (NEW): NDFI / private-credit downturn surprise risk | Real but managed | JPM-specific exposure remains conservative; system-level risk acknowledged by management |
Overall: Five bull points strongly confirmed (six existing, one inflecting), four bear points actively materializing (valuation, NII, wholesale credit, capital trajectory, expense), one new bear point identified but well-managed (NDFI). The thesis balance has shifted modestly toward the bear side relative to our Q2 framework — not because the operating story has weakened (it has not), but because forward arithmetic on capital return, expense, and credit cycle has tightened. The right rating remains Hold.
Action: Maintaining Hold. Q3 was operationally a clean confirmation of the franchise quality. The forward setup is a function of (a) where the stock trades into year-end — an AI-complex / regional-bank / NBFI shock would create the entry point that supports an upgrade, (b) whether wholesale credit normalization is contained at idiosyncratic single-names or accelerates into a directional shift, and (c) whether the regulatory recalibration delivers meaningful capital relief in 2026. None of these are resolved today; the right posture is patience. Our upgrade triggers from the Q2 initiation remain in place: a 10-15% drawdown without thesis impairment, OR clear evidence that the wholesale credit cycle is contained, OR a meaningful Basel III Endgame capital-relief outcome would each independently move us to Outperform.